Clinical characteristics of patients requiring emergency hospitalization due to immune-related adverse events: a retrospective study
2024

Emergency Hospitalization Due to Immune-Related Adverse Events in Cancer Patients

Sample size: 96 publication 10 minutes Evidence: moderate

Author Information

Author(s): Ikeda Tatsuki, Nihei Satoru, Saito Kazuki, Asaka Junichi, Kudo Kenzo

Primary Institution: Iwate Medical University Hospital

Hypothesis

This study aimed to investigate the clinical characteristics of patients requiring emergency hospitalization due to immune-related adverse events during immune checkpoint inhibitor therapy.

Conclusion

Emergency hospitalization due to immune-related adverse events is a significant concern in immune checkpoint inhibitor therapy, highlighting the need for early monitoring and management.

Supporting Evidence

  • 96 out of 1009 patients treated with immune checkpoint inhibitors required emergency hospitalization due to immune-related adverse events.
  • 34.4% of patients presented with dyspnea and fatigue as chief complaints.
  • 8.3% of hospitalized patients died due to immune-related adverse events.
  • 33.3% of patients resumed immune checkpoint inhibitor therapy after hospitalization.

Takeaway

Some cancer treatments can cause serious side effects that make patients very sick and need to go to the hospital. It's important for doctors to watch for these problems early.

Methodology

This retrospective study evaluated patients who received immune checkpoint inhibitors at Iwate Medical University Hospital and required emergency hospitalization due to immune-related adverse events.

Potential Biases

The reliance on medical records for data may lead to inaccuracies.

Limitations

The study's retrospective design may introduce bias, and it was conducted at a single institution, limiting generalizability.

Participant Demographics

The mean age of hospitalized patients was 73 years, with 75% being male, and a high proportion undergoing treatment for lung cancer.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s40780-024-00400-7

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication